What are the potential advantages and challenges of transitioning from earlier GLP-1 receptor agonist formulations requiring frequent dosing to newer options like Dulaglutide, Semaglutide, and oral formulations
Retatrutide: The Triple Agonist Thats Redrawing the Map of Obesity Medicine Updated with TRIUMPH-1 and TRANSCEND-T2D-1 Phase 3 data presented at the ADA 86th Scientific Sessions (June 2026) The Short Version Retatrutide (LY3437943, Eli Lilly) is an investigational, once-weekly subcutaneous peptide that hits three metabolic receptors at once: GIP, GLP-1, and glucagon
The Cedars-Sinai pharmacy can fill prescriptions for oral semaglutide for Cedars-Sinai patients
The powder may have been damaged during shipping (exposure to heat or excessive vibration) or may have a manufacturing defect
The agency has been reviewing thyroid cancer risk signals, pancreatitis associations, and, more recently, potential psychiatric effects including suicidality, though the evidence for the latter has been largely reassuring in major pharmacovigilance analyses [6]
The journal Drug Design, Development and Therapy echoes these concerns
